Melina I Manolas

Dr. Melina Manolas is a board-certified internal medicine physician, endocrinologist, and Assistant Professor of Clinical Medicine at Weill Cornell Medical College. She completed her MD and MPH degrees at Tulane University, residency at NewYork-Presbyterian/Weill Cornell, and fellowship in Endocrinology, Diabetes, and Metabolism at Montefiore–Albert Einstein. She is a general endocrinologist but specializes in hepato-endocrinology with a focus on MASLD and MASH.

Oren K Fix

Oren Fix, MD, MSc, FAASLD is Professor of Medicine, Medical Director of Liver Transplantation, a Lead Informatics Physician, and the Associate Program Director of the Clinical Informatics Fellowship at the University of North Carolina at Chapel Hill. He is board certified in Clinical Informatics, a certified Epic Physician Builder, Chair of the Epic Hepatology Specialty Steering Board, and an Epic Exemplar for hepatology. He serves the AASLD as Councilor-at-Large on the Governing Board, Associate Editor of Liver Transplantation, and co-chair of the Workforce Task Force.

Cynthia Levy

I am a Professor of Medicine in the Division of Digestive Health and Liver Diseases and is the Associate Director of the Schiff Center for Liver Diseases at the University of Miami.

My clinical research program focuses on understanding the natural history, managing symptoms, and designing and implementing clinical trials for autoimmune and cholestatic liver diseases, as well as the porphyrias. I also serve as chair for the AASLD practice guidelines committee and as a steering committee member for the Cholestatic and Autoimmune Liver Diseases SIG in AASLD.

Christopher L Bowlus

Christopher L. Bowlus is the Lena Valente Professor and Chief of the Division of Gastroenterology and Hepatology at the University of California Davis School of Medicine. Dr. Bowlus has an active research program that bridges the basic and clinical aspects of PBC and PSC with the goal to bring more effective treatments to patients with these diseases. He is a founding member of the International PSC Study Group (IPSCSG) and leads the US-based Consortium for Autoimmune Liver Disease (CALiD).

Bettina Hansen

Bettina Hansen, PhD, is Professor of Clinical Biostatistics at Erasmus MC, the Netherlands, and at the University of Toronto, Canada. She is Program Director of the MSc Health Sciences Research Program at Erasmus MC. She studied statistics at the Institute of Mathematical Statistics, University of Copenhagen, Denmark, and earned her PhD on treatment effects in chronic hepatitis B and C from the Department of Gastroenterology and Hepatology, Erasmus MC.

Marlyn J. Mayo

Professor of Internal Medicine
Division of Digestive & Liver Diseases
UT Southwestern Medical Center
Dallas, Texas
Longstanding interest in cholestatic and autoimmune liver disorders

Marco M Carbone

Marco Carbone is Professor of Hepatology at the University of Milano-Bicocca and a honorary hepatologist at the Niguarda Liver Transplant Centre in Milan. His research is dedicated to understanding the mechanisms underlying autoimmune and cholestatic liver disorders. He founded and co-chairs the Italian PBC and PSC Registries, sits on the steering committee of the Global PBC Study Group, and serves as Deputy Chair of the PBC Foundation Medical Advisory Board.

Kris V. Kowdley

Dr. Kris Kowdley is Director of Liver Institute Northwest and professor, Elson S. Floyd College of Medicine at Washington State University and Senior Scientific Advisor and Medical Director at Velocity Clinical Research. He received his B.S. in Biology and Anthropology as a member of the Dean's List at Columbia University, and his medical degree from Mount Sinai School of Medicine. He completed his internship and residency at Oregon Health Science University and a Fellowship in Gastroenterology and Hepatology at Tufts University School of Medicine.

Ana Lleo

I obtained my degree in Medicine from the University of Milan, Italy, in 2000, completed my clinical training and received the Board Certification in Internal Medicine and Hepatology in 2006. In the same year I started my PhD at the University of California-Davis (Davis, CA, USA) in the division of Clinical Immunology and Rheumatology, under the supervision of Prof. M. Eric Gershwin. During my PhD I focused on the pathogenesis of PBC and the biliary specificity, a major unanswered question in PBC.

Subscribe to